Turkey Patent System

Turkey has developed a rapidly growing domestic defense industry, with significant patent activity in electronics, drone technology, and aerospace. Key companies: ASELSAN (Ankara — defense electronics: radar, electronic warfare, communications, avionics; publicly traded company listed on Borsa Istanbul; exports to NATO allies and other markets; significant patent portfolio in millimeter-wave radar, software-defined radio, and satellite communications); Baykar (Istanbul — Bayraktar TB2 and Akıncı unmanned aerial vehicles [UAVs]; one of the world's most commercially successful drone manufacturers [exported to 30+ countries]; Baykar's drone technology represents Turkish state-of-the-art in electric propulsion, autopilot software, and composite airframe manufacturing; the TB2's combat record in multiple conflicts drove international demand); TAI — Turkish Aerospace Industries (Ankara — fixed-wing aircraft including the HÜRJET jet trainer, HÜRKUŞ turboprop, and the TAI TF-X/KAAN 5th-generation fighter [first flight January 2023]; TAI holds patents in aerospace manufacturing and composite materials). Turkish defense IP strategy: Turkish defense companies file patents primarily at TURKPATENT (national) and through the PCT (international, for export markets). Defense patents may be subject to Turkish state secrecy orders under law — classified defense patents are not published. Turkey's defense IP is increasingly relevant to NATO members purchasing Turkish-manufactured systems, raising export control and IP licensing considerations in NATO supply chains.

Turkey has one of Europe's largest pharmaceutical markets (top-5 by market size in the WHO European region) and a significant domestic generic drug manufacturing industry. Turkish pharmaceutical IP framework under Law No. 6769: (1) Turkish SPC (Supplementary Protection Certificate): Turkey implements its own SPC system under Art. 121–138 Law No. 6769 — this is a DOMESTIC Turkish law SPC, NOT the EU SPC Regulation 469/2009 (which applies only to EU member states). Turkish SPCs are granted by TURKPATENT based on marketing authorization by TITCK (Türkiye İlaç ve Tıbbî Cihaz Kurumu — Turkish Medicines and Medical Devices Agency). Maximum Turkish SPC duration = 5 years; (2) Patent linkage: Turkey implements a pharmaceutical patent linkage system — TITCK requires generic drug marketing authorization applicants to certify that the reference product's relevant patents do not block entry, or that the applicant has challenged the relevant patents. Originator companies can file preliminary injunctions (ihtiyati tedbir) in Turkish courts to block TITCK generic approvals while patent challenges are resolved; (3) Data exclusivity: Turkey provides 6 years of data exclusivity for reference medicinal products (2 years shorter than the EU's 8+2+1 standard). This is important for biosimilar market entry timing; (4) Local generic industry: Turkish generic companies include Abdi İbrahim (Istanbul), Deva Holding, Nobel İlaç, and Zentiva Turkey (now part of Zentiva/Sanofi divestiture). Turkish generic companies are active pharmaceutical patent challengers, and TURKPATENT patent cancellation proceedings are commonly used in Turkish pharmaceutical litigation.

Turkey is a major automotive manufacturing hub — the 7th largest vehicle producer in Europe and a significant exporter to EU markets. Key manufacturers with Turkish operations: Ford Otosan (Ford-Koç Holding joint venture, Kocaeli/Gölcük/Eskişehir — the world's largest Ford Transit manufacturing facility, now producing the all-electric E-Transit; significant patent activity in electric van manufacturing); Fiat Tofaş (Stellantis-Koç Holding JV, Bursa — Fiat Doblo and its electric variants; Tofaş engineers contribute to Stellantis global R&D); Renault Turkey (Oyak Renault, Bursa — Renault Clio, Megane, Express van manufacturing; Turkish R&D contributions); Toyota Manufacturing Turkey (Sakarya); Hyundai Assan (Izmit). Turkish automotive patent strategy: many Turkish automotive patents are filed by global OEMs' Turkish subsidiaries, with IP ownership typically remaining with the global parent. Locally-developed innovations (process improvements, localized components, fleet management software) may be owned by Turkish subsidiaries. The EU customs union means Turkish-manufactured vehicles face no EU import tariffs, making Turkish production locations competitive — protecting process innovation patents is commercially valuable for maintaining this cost advantage. TOGG (Automobile Joint Venture Group, Bursa — Turkish domestic electric vehicle manufacturer, launched 2023) represents a new category of Turkish automotive IP: a domestic brand building its own patent portfolio in EV powertrain, ADAS, and connected vehicle technology.

You CAN validate a European Patent in Turkey, but the Unitary Patent does NOT cover Turkey. Here is the distinction: (1) EP patent validation in Turkey: Turkey joined the European Patent Convention (EPC) on November 1, 2000. This means that an applicant who obtains a European Patent from the EPO can choose to validate it in Turkey by paying the Turkish validation fee, filing a Turkish translation (Turkish is required), and recording the patent at TURKPATENT. The resulting nationally-validated EP patent is then a Turkish patent, enforceable under Turkish law in Turkish courts, subject to Turkish patent maintenance fees. This is the standard route for most international applicants seeking Turkish patent protection — EPO examination (which applies the EPO's rigorous patentability standards) combined with Turkish national validation; (2) Unitary Patent does NOT cover Turkey: the Unitary Patent (a single patent covering multiple EU member states, administered by the EPO and enforced by the UPC) requires EU membership for participating states. Turkey is not an EU member. When an applicant obtains a Unitary Patent, it covers UPC participating EU member states (Germany, France, Italy, Netherlands, Spain, and others), but NOT Turkey. For Unitary Patent holders who also want Turkish protection, a separate Turkish EP validation is required; (3) Practical implication: a patent filing strategy targeting major European markets plus Turkey needs to: (a) file an EP application at the EPO; (b) request Unitary Patent status after EPO grant for EU-wide coverage; AND (c) separately validate the EP patent in Turkey (TURKPATENT national validation). This adds the Turkish translation requirement and Turkish validation fees but covers Turkey's 85 million consumer market, a growing tech sector, and a significant manufacturing base tied to EU supply chains via the customs union.

Turkey has a 12-month grace period under Article 83 of the Industrial Property Code (Law No. 6769), which protects applicants against their own prior disclosures made within 12 months before the Turkish patent filing date. Specifically: (1) Covered by grace period: disclosures made by the applicant/inventor — conference presentations, journal articles, product demonstrations, sales, or other public disclosures — that originated from the applicant and occurred within 12 months before the Turkish filing date. These are not treated as prior art that destroys novelty for the Turkish national application; (2) NOT covered: independent third-party disclosures. If an independent party (not the applicant or inventor) publishes the same invention before the Turkish filing date, that disclosure IS prior art against the Turkish application. The grace period does not protect against independent parallel discoveries that become public; (3) US comparison: the Turkish grace period is structurally similar to the US AIA § 102(b)(1) one-year grace period — both protect the applicant's own prior disclosures for 12 months. Both also exclude independent third-party disclosures from the grace period; (4) EPC comparison: the EPC (European Patent Convention) has NO grace period — EPC Art. 54 requires strict absolute novelty. Any public disclosure before the filing/priority date is prior art, including the inventor's own disclosure. The only narrow exceptions under EPC Art. 55 (officially recognized international exhibition, evident abuse) do not constitute a meaningful commercial grace period; (5) Important caveat for EP validation in Turkey: even though Turkey has a domestic grace period for TURKPATENT national filings, the EPC's strict absolute novelty applies to the EPO examination of an EP application. If an applicant disclosed before filing an EP application, the EPO will treat that disclosure as prior art in examination — the Turkish grace period does not help with EP examination. If the EP application overcomes this (e.g., by claiming a disclosure exception under EPC Art. 55), then the Turkish validation of the resulting EP patent is valid. But practically: file before disclosing for EP applications targeting Turkey via the EP route.

Turkey's utility model (faydalı model) under Articles 138–150 of Law No. 6769 provides 10 years of protection for novel and inventive objects, systems, or methods. Key distinctions from Turkish patents: (1) Lower inventive step: Turkish utility models require novelty and a lower inventive step than patents. The utility model standard is whether the invention has an 'inventive feature' — a lower bar that incremental improvements typically meet; (2) Broader scope than many EU utility models: unlike Italian utility models (objects/products only) or German utility models (objects only, not processes), Turkish utility models can cover products, devices, systems, and potentially methods/processes — the Turkish law is broadly worded; (3) No substantive examination: Turkish utility models are registered without substantive examination by TURKPATENT. TURKPATENT conducts a prior art search and formality review, then registers the utility model. Validity (novelty and inventive step) is NOT confirmed by TURKPATENT before registration — validity can only be challenged in infringement proceedings or cancellation actions; (4) 10-year term: utility models cannot be converted to or extended as patents. If protection beyond 10 years is needed, a separate patent application must be filed during the utility model's pendency; (5) Speed and cost: utility model registration in Turkey is typically faster (6–12 months) and cheaper than patent examination (3–7 years). This makes utility models attractive for Turkish SMEs, manufacturers, and exporters needing quick protection; (6) When to use: Turkish utility models are valuable for manufacturers in Turkey's large SME sector (textiles, machinery, food processing, construction), where incremental product improvements need protection but the inventive step threshold for a patent would be difficult to meet. Also useful for products with shorter life cycles than a 20-year patent term. Note: pharmaceutical SPCs require a patent (not a utility model) as their base.

Turkey's EU Customs Union (established by Decision 1/95 of December 22, 1995, effective January 1, 1996) eliminates tariffs on industrial goods traded between Turkey and the EU. The customs union has significant implications for IP strategy in Turkey: (1) EU-aligned IP standards as customs union condition: Turkey has been required, as a condition of customs union participation, to align its IP law with EU standards. This drove major Turkish IP law reforms, including the Industrial Property Code No. 6769 (2017) which modernized Turkish patent law, improved TRIPS compliance, and adopted EU-equivalent IP enforcement standards. The customs union is a de facto regulatory harmonization mechanism for Turkish IP law; (2) For patent holders selling in both EU and Turkey: the EU patent exhaustion doctrine (first sale within the EU exhausts EU-wide patent rights) does NOT apply between the EU and Turkey, because Turkey is not an EU/EEA member. Parallel imports from Turkey to the EU (or EU to Turkey) may still constitute patent infringement in the destination country, depending on the applicable national law. Turkish law provides for national exhaustion of rights — a patent right is exhausted in Turkey when the patent holder first puts the product on the Turkish market, but this does not exhaust the holder's rights in EU countries; (3) Supply chain and manufacturing IP: many EU companies manufacture products in Turkey for export back to the EU under the customs union (zero-tariff access). These manufacturing arrangements require clear IP ownership and licensing terms — EU companies with Turkish manufacturing partners should document which party owns any process improvements or product modifications made in Turkish facilities. The employee inventor provisions of Turkish law may vest Turkish-employee-generated innovations in the Turkish employer entity unless properly assigned; (4) TRIPS compliance: Turkey is a WTO TRIPS Agreement member, requiring minimum IP standards. The customs union reinforced TRIPS alignment and created pressure to reduce counterfeit goods and IP infringement that adversely affects EU exporters into Turkey.

Turkey's defense industry has grown significantly — defense exports have increased from approximately $248 million in 2002 to over $4 billion annually by the early 2020s. Patent IP considerations for Turkish defense tech include: (1) Government ownership and national security: under Turkish law, the Turkish government can claim ownership or use of inventions related to national defense and security. TURKPATENT can withhold publication of patent applications and impose secrecy orders (gizlilik kararı) under Law No. 6769 when the invention has national security implications. Defense companies filing patents in Turkey should be aware that TURKPATENT can classify certain applications; (2) SSB (Presidency of Defense Industries — Savunma Sanayii Başkanlığı) procurement IP: Turkish defense procurement contracts through SSB typically require technology transfer provisions and address IP ownership for innovations developed in the performance of defense contracts. Similar to US DoD procurement, Turkish defense contracts negotiated with SSB contain provisions about background IP (IP owned before the contract) and foreground IP (IP created under the contract). Foreign defense contractors providing technology to Turkey through SSB procurement must carefully negotiate these terms; (3) Baykar TB2 and export markets: Baykar's Bayraktar TB2 drone has been exported to over 30 countries. Baykar's patent filings cover drone autopilot systems, propulsion, and airframe design. The IP licensing structure for drones sold to military customers (typically government-to-government sales) is addressed in separate technology transfer agreements; (4) ASELSAN cross-licensing: ASELSAN (publicly traded on Borsa Istanbul) participates in international defense consortiums and NATO programs that involve cross-licensing of electronics and radar technology; (5) NATO interoperability: as a NATO member, Turkey participates in NATO standardization (STANAG) — technologies incorporated into NATO standards may have FRAND-like licensing implications within NATO.